CHINA AOXING PHARMACEUTICAL COMPANY, INC. — Form D
CHINA AOXING PHARMACEUTICAL COMPANY, INC. of JERSEY CITY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2010-02-08. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-02-08
- Form: D
- Accession: 0001060426-10-000002
- Industry: Pharmaceuticals
- Exemptions: 06, 46
- Total offering: $5.0M
- Amount sold: $5.0M
- Minimum investment: $5K
- Investors: 15
- Date of first sale: 2009-08-06
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-138526
Issuer
- Name: CHINA AOXING PHARMACEUTICAL COMPANY, INC.
- CIK: 0001060426
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Address: 15 EXCHANGE PLACE, SUITE 500, JERSEY CITY, NJ, 07302
- Phone: 646-367-1747
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Jun Min | Director | Jersey City, NJ |
| John O'Shea | Director | Eden Prairie, MN |
| Howard Sterling | Director | Jersey City, NJ |
| Guozhu Xu | Director | Jersey City, NJ |
| Zhenjiang Yue | Director | Jersey City, NJ |
| Hui Shao | Executive Officer | Jersey City, NJ |
| Zhenjiang Yue | Executive Officer | Jersey City, NJ |
More